Skip to main content
OpenTrials
Completed

NCT Number: NCT00175175

Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients

Patients with hip fractures have suffered the most devastating consequence of osteoporosis; and yet, they are rarely if ever tested or treated for the condition, even though they remain at high risk of recurrent fracture.

We hypothesize that, compared with usual care, an allied health professional-run osteoporosis service (case management) will be able to increase testing and treatment of osteoporosis in patients at high risk of fracture.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Osteoporosis Bone Diseases Bone Diseases, Metabolic Femoral Fractures Fractures, Bone Hip Fracture Hip Fractures Hip Injuries Leg Injuries Metabolic Diseases Musculoskeletal Diseases Nutritional and Metabolic Diseases Wounds and Injuries

Age range

50 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Alberta Hospitals

Edmonton, Alberta, T6G 2B7, Canada

About this study

Patients with hip fractures have suffered the most devastating consequence of osteoporosis; and yet, they are rarely if ever tested or treated for the condition, even though they remain at high risk of recurrent fracture.

We hypothesize that, compared with usual care, an allied health professional-run osteoporosis service (case management) will be able to increase testing and treatment of osteoporosis in patients at high risk of fracture.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • hip fracture patient > 50 years of age
  • able to give consent (or proxy consent available)
  • lives within health region
  • no contraindications to bisphosphonate therapy

Exclusion criteria

  • refuses to participate or consent
  • dementia or delirium without a proxy consent available
  • nursing home or longterm care
  • pathologic fracture
  • chronic glucocorticoid use
  • already receiving prescription osteoporosis treatment (calcium and vitamin D do not preclude inclusion)

Treatment and study plan

Allied health professional-run osteoporosis service ("case-management")

Behavioral

Primary outcomes

  1. The proportion of patients taking bisphosphonate therapy within 6 months of hip fracture

Secondary outcomes

  1. Proportion of patients taking prescription osteoporosis treatment at 6 months and 12 months

  2. Proportion in receipt of a BMD test at 6 months and 12 months

  3. Proportion still adherent to osteoporosis treatments at 6 months and 12 months

  4. Proportion of patients with recurrent fractures at 6 months and 12 months

  5. Cost effectiveness analyses

Sponsors and collaborators

Lead sponsor

University of Alberta

Other

Collaborators

  • Alberta Heritage Foundation for Medical Research
  • Royal Alexandra Hospital

Registry information

Important dates

Study start
2002
First posted
Sep 15, 2005
Registry last updated
Sep 15, 2006

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.